DARALYN KAWAMOTO PHARMD
Prescription History 1619216439
Pharmacist in West Linn, OR

NPI Status: Active since February 14, 2013

Contact Information

22000 SALAMO RD
WEST LINN, OR
ZIP 97068
Phone: (503) 650-6426

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DARALYN KAWAMOTO PHARMD, an active Pharmacist specialist practicing in West Linn, OR. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 269 documented patient claims. Among these therapy options, the most frequently utilized medication is Arexvy, which accounts for 182 claims alone.

Medication Index

No matching medications currently found on file.

Arexvy

Generic Formulation: Rsvpref3 Antigen/As01e/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 182
30-Day Fills 182.0
Days Supply 182
OR State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$308.45

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 25
OR State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills18.1
Peer Average Days Supply18
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.9% more claims than the standard regional baseline profile for OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,676.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$67.04

State Avg Cost Per Claim

$62.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 62
30-Day Fills 62.0
Days Supply 62
OR State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills37.8
Peer Average Days Supply43
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 67.6% higher than the standard regional baseline profile for OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,112.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$211.50

State Avg Cost Per Claim

$197.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DARALYN KAWAMOTO PHARMD provides transparency into local medical care patterns within West Linn, OR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.